Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a23ce2d56b418043

Jump to content

Tridihexethyl

From Wikipedia, the free encyclopedia
Tridihexethyl
Clinical data
ATC code
Identifiers
  • 3-cyclohexyl-N,N,N-triethyl-3-hydroxy-3-phenylpropan-1-aminium
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H36NO+
Molar mass318.525 g·mol−1
3D model (JSmol)
  • OC(c1ccccc1)(CC[N+](CC)(CC)CC)C2CCCCC2
  • InChI=1S/C21H36NO/c1-4-22(5-2,6-3)18-17-21(23,19-13-9-7-10-14-19)20-15-11-8-12-16-20/h7,9-10,13-14,20,23H,4-6,8,11-12,15-18H2,1-3H3/q+1 checkY
  • Key:NPRHVSBSZMAEIN-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

Tridihexethyl (which is commonly used as its chloride salt, tridihexethyl chloride) is an anticholinergic, antimuscarinic and antispasmodic drug. It may be used, usually in combination with other drugs, to treat acquired nystagmus[1] or peptic ulcer disease.[2] Many patients discontinue the drug because of unwanted side effects.

It is also known as Pathilon or Propethonum. [3]

References

[edit]
  1. Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ (November 1991). "Effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride". Neurology. 41 (11): 1737–41. doi:10.1212/wnl.41.11.1737. PMID 1944902. S2CID 23270800.
  2. "DB00505 (Tridihexethyl)". DrugBank.
  3. "Tridihexethyl". Mongabay.com. Archived from the original on 2007-11-15.